Biopharmaceutical
Pharmaceutical
Health

Global Blood Therapeutics

1,292

$76.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.56 (-1.99%) Today
$0.00 (0.00%) As of 7:32 PM EST after-hours

Why Robinhood?

You can buy or sell GBT and other stocks, options, ETFs, and crypto commission-free!

About GBT

Global Blood Therapeutics, Inc. Common Stock, also called Global Blood Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Read More It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.

CEO
Ted W. Love
Employees
171
Headquarters
South San Francisco, California
Founded
2011
Market Cap
4.52B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.89M
High Today
$79.45
Low Today
$75.21
Open Price
$78.54
Volume
1.43M
52 Week High
$79.95
52 Week Low
$34.92

Collections

Biopharmaceutical
Pharmaceutical
Health
Therapy
Biotechnology
Medical
Technology
2015 IPO

GBT News

New York TimesDec 7

Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?

The medical costs do not begin to capture the economic burden. Many adults with sickle-cell disease are disabled to some degree, and many have brain damage, mak
261

GBT Earnings

-$1.07
-$0.97
-$0.88
-$0.78
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 27, After Hours

You May Also Like

TELL
NBB
SNY
UBR
DLHC
PYX
NRGD
JSMD
QUS
IEFA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy GBT

Market Price$76.89
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell GBT stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up